RIFAMPICIN Safety Questions, RIFAMPICIN Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides unique information about RIFAMPICIN. Our extensive database of RIFAMPICIN adverse events and RIFAMPICIN warnings is updated regularly. If you have questions, you can post them to one of our health experts or ask others in our broad patient community.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Ask Our Health Experts about RIFAMPICIN
RIFAMPICIN Safety Reports
Total RIFAMPICIN reports: 84.RIFAMPICIN FDA safety alerts: No.
Reported deaths: 26 Reported hospitalizations: 35.
Take RIFAMPICIN Side Effects Survey or Share Your RIFAMPICIN Story. Read More Here.
Showing 1-75 of 84 Next >
Consumer or non-health professional from JAPAN reported RIFAMPICIN problem on July 24, 2007. Female patient, 71 years of age, was diagnosed with tuberculous pleurisy and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: pancytopenia. RIFAMPICIN dosage: unknown. During the same period patient was treated with ISONIAZID, PYRAZINAMIDE, ETHAMBUTOL HYDROCHLORIDE. Patient recovered.RIFAMPICIN problem was reported by a Consumer or non-health professional from IRELAND on July 18, 2007. Male patient, child 3 years of age, was diagnosed with meningitis meningococcal and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: haemolytic uraemic syndrome, haemorrhage, hypovolaemic shock. RIFAMPICIN dosage: unknown. Patient died on 11/14/2004.
Consumer or non-health professional from IRELAND reported RIFAMPICIN problem on July 18, 2007. Male patient, child 3 years of age, was diagnosed with meningitis meningococcal and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: congenital anomaly, haemolytic uraemic syndrome, hypovolaemic shock, peritoneal haemorrhage. RIFAMPICIN dosage: unknown. Patient died on 11/14/2004.
RIFAMPICIN problem was reported by a Consumer or non-health professional from JAPAN on Aug 01, 2007. Male patient, 76 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: atelectasis. RIFAMPICIN dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE, LEVOFLOXACIN. Patient recovered.
Consumer or non-health professional from JAPAN reported RIFAMPICIN problem on Aug 10, 2007. Male patient, 76 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, pruritus, subileus, urinary retention. RIFAMPICIN dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE, LEVOFLOXACIN. Patient recovered.
RIFAMPICIN problem was reported by a Pharmacist from UNITED STATES on Aug 23, 2007. Female patient, weighting 105.2 lb, was diagnosed with tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, blood bilirubin increased, pulmonary tuberculosis. RIFAMPICIN dosage: 600MG PO DAILY. During the same period patient was treated with FUROSEMIDE, SENNA, DOCUSATE, LEVOFLOXACIN, ACETAMINOPHEN, METOCLOPRAMIDE, LORAZEPAM. Patient was hospitalized. Patient recovered.
Physician from JAPAN reported RIFAMPICIN problem on Aug 27, 2007. Male patient, 78 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: atelectasis, pruritus, subileus, urinary retention. RIFAMPICIN dosage: unknown. During the same period patient was treated with ISONIAZID, ETHAMBUTOL HYDROCHLORIDE, PYRAZINAMIDE, LEVOFLOXACIN. Patient recovered.
RIFAMPICIN problem was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, 54 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: interstitial lung disease, liver disorder, respiratory failure. RIFAMPICIN dosage: 150 MG, QD, ORAL 300 MG, QD, ORAL 450 MG, QD, ORAL. During the same period patient was treated with ETHAMBUTOL HYDROCHLORIDE, LEVOFLOXACIN, STREPTOMYCIN, MAGMITTO, NOVOLIN R. Patient died.
Consumer or non-health professional from SPAIN reported RIFAMPICIN problem on Sept 03, 2007. Female patient, 73 years of age, was diagnosed with pulmonary tuberculosis and was treated with RIFAMPICIN. After drug was administered, patient experienced the following problems/side effects: nausea, neuritis, vomiting. RIFAMPICIN dosage: unknown. Patient was hospitalized. Patient recovered.
Showing 1-75 of 84 Next >